Leuco methylthioninium

甲磺酸氢甲硫堇

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameLeuco methylthioninium
Drug Alias Nameleuco-methylthioniniumHydromethylthionine MesylateLMT-XTRX-0237Leuco-MTx +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsCognitive DysfunctionFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[21] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaurx Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesMediforum Pharmaceutical Co LtdTauRx Pharmaceuticals LtdTaurx Pharmaceuticals +[4] 
Inactive CompaniesDmed Biopharmaceutical Co LtdPiramal Healthcare Uk Ltd
Active IndicationsCognitive DysfunctionAlzheimer Disease
Inactive IndicationsFrontotemporal Dementia

Other Information

ATC CodeN/A
Related LinksN/A